title: Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.
abstract: Fibrinolytic activity in plasma euglobulin fractions can be increased by oral administration of stanozolol. This increase is not caused by increased synthesis or release of tissue-type plasminogen activator. A decreased level of fast acting t-PA inhibition is very probably the cause of the higher activity. These results suggest that this inhibition has a regulatory role on fibrinolysis in vivo.
mesh_terms: D000328:Adult; D005342:Fibrinolysis / Q000187:drug effects; D006023:Glycoproteins / Q000502:physiology*; D006801:Humans; D007700:Kinetics; D010960:Plasminogen Activators / Q000037:antagonists & inhibitors*; D015849:Plasminogen Inactivators; D012016:Reference Values; D013197:Stanozolol; D013997:Time Factors
chemical_list: D006023:Glycoproteins; D015849:Plasminogen Inactivators; D013197:Stanozolol; D010960:Plasminogen Activators